home.aspx

 
.

BISPECIFIC ANTIBODIES DESIGN

August 20-21, 2019
Washington, D.C, USA (United States of America)
Bispecific antibodies continue to show significant and impressive therapeutic value. While the development of bispecific antibodies is an evolving field, many challenges are still awaiting to be solved by experts in the field including target selection, better understanding of their mechanism of action, along with the combination selection of targets. CHI’s Second Annual Bispecific Antibody Design conference will delve directly into the technical challenges of bispecific development to improve your candidates’ translatability into the clinic.